Advertisement

Physician's First Watch Archive

Medical news from NEJM Journal Watch

March 5, 2015

By Kelly Young

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

People with a high genetic risk for developing coronary heart disease appear to derive greater benefit from statins than people with …

By The Editors

The FDA has approved nivolumab (Opdivo) to treat metastatic squamous non-small cell …

By Robert W. Rebar, MD

The gonadotropin-releasing hormone (GnRH) agonist goserelin helps protect against ovarian failure in women undergoing chemotherapy for breast cancer, according to an international study in the New England Journal of Medicine.

Over 250 premenopausal women with hormone-receptor-negative early breast cancer were randomized …

March 4, 2015

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH

The Affordable Care Act will be challenged in the U.S. Supreme Court on Wednesday (King v. Burwell) over complaints that the law …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH

Three papers in the BMJ take a close look at screening programs and the potential for overdiagnosis.

The first analysis examines screening for abdominal aortic aneurysms (in the U.S., one-time screening is recommended for men aged 65–75 who've ever …

By Kelly Young

Edited by David G. Fairchild, MD, MPH

The majority of asymptomatic thyroid nodules do not grow significantly or progress to cancer, according to a JAMA study.

In Italy, a population with …

By Kristin J. Kelley

Edited by David G. Fairchild, MD, MPH

Men who use testosterone products to treat low testosterone may be at increased risk for myocardial infarction, stroke, and death, …

By The Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Clinical Practice Center: Clinicians …

Pages